January 5, 2025 - 10:26

In a recent discussion, finance expert Dave Ramsey provided valuable insights into the housing market, pinpointing the best times for prospective homebuyers to enter the market in 2025. He emphasized that timing is crucial when it comes to making such a significant investment. According to Ramsey, the ideal window for purchasing a home will likely occur during the spring months, when inventory tends to be higher and competition more favorable for buyers.
However, he also cautioned against buying during certain periods, particularly when market conditions are less favorable. Ramsey highlighted that waiting for the right moment could potentially save buyers tens of thousands of dollars. He advised individuals to remain vigilant and informed about market trends, interest rates, and economic indicators that could influence their homebuying decisions. By strategically timing their purchase, buyers can maximize their investment and minimize financial risk in an ever-changing real estate landscape.
May 17, 2026 - 08:31
How Investors Are Reacting To NVE (NVEC) Steady Earnings And Maintained Quarterly DividendNVE Corporation has released its full-year results for the period ending March 31, 2026, posting revenue of US$26.33 million and net income of US$15.2 million. The company also confirmed a...
May 16, 2026 - 22:25
Risky Integration or Rewarding Returns? The Stakes of SoundHound's LivePerson Acquisition.SoundHound AI`s acquisition of LivePerson is drawing mixed reactions from investors, with the immediate fallout hitting the stock price. The deal, which combines SoundHound`s voice AI technology...
May 16, 2026 - 10:38
Bank of Hawaii, Glacier Bancorp, and Wintrust Financial Shares Plummet, What You Need To KnowShares of several regional banks took a sharp hit in afternoon trading Wednesday after the latest inflation report came in hotter than expected. The April Consumer Price Index rose 3.8%, a figure...
May 15, 2026 - 17:39
Plus Therapeutics Shares First Quarter 2026 Financial Results and Updates on REYOBIQ and CNSide ProgressHOUSTON, May 15, 2026 -- Plus Therapeutics, a healthcare company focused on precision diagnostics and radiopharmaceuticals for central nervous system cancers, reported its financial results for the...